Base de dados : HANSEN
Pesquisa : ANTITUBERCULOSOS/USO TERAP [Descritor de assunto]
Referências encontradas : 6 [refinar]
Mostrando: 1 .. 6   no formato [Detalhado]

página 1 de 1

  1 / 6 HANSEN  
              next record last record
seleciona
para imprimir
Id:25083
Autor:Anon
Título:The US-Japan Cooperative Medical Science Program Tuberculosis and leprosy Panel's 36th Annual Research Conference, New Orleans, Louisiana, USA, 15-17 July 2001
..-
Fonte:s.l; s.n; 2002. 23 p. .
Conferência:Apresentado em: Leprosy Panel annual research conference, 36, New Orleans, 15-17 july 2001.
Descritores:MYCOBACTERIUM/clas
MYCOBACTERIUM/cresc
MYCOBACTERIUM/imunol
MYCOBACTERIUM/patogen
MICOBACTERIAS ATIPICAS/cresc
MICOBACTERIAS ATIPICAS/imunol
MICOBACTERIAS ATIPICAS/isol
MICOBACTERIAS ATIPICAS/metab
MICOBACTERIAS ATIPICAS/fisiol
MICOBACTERIAS ATIPICAS/patogen
MYCOBACTERIUM AVIUM/cresc
MYCOBACTERIUM AVIUM/imunol
MYCOBACTERIUM AVIUM/patogen
MYCOBACTERIUM BOVIS/imunol
MYCOBACTERIUM BOVIS/patogen
MYCOBACTERIUM LEPRAE/imunol
MYCOBACTERIUM LEPRAE/patogen
MYCOBACTERIUM TUBERCULOSIS/cresc
MYCOBACTERIUM TUBERCULOSIS/imunol
MYCOBACTERIUM TUBERCULOSIS/isol
MYCOBACTERIUM TUBERCULOSIS/patogen
ANTITUBERCULOSOS/admin
ANTITUBERCULOSOS/ef adv
ANTITUBERCULOSOS/uso terap
COOPERACAO INTERNACIONAL
 COOPERACAO TECNICA
 VACINA BCG/admin
Limites:HUMANO
ANIMAL
Localização:BR191.1; 09068/s


  2 / 6 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:18516
Autor:Newton, Sandra M; Lau, Clara; Gurcha, Sudagar S; Besra, Gurdyal S; Wright, Colin W
Título:The evaluation of forty-three plant species for in vitro antimycobacterial activities; isolation of active constituents from Psoralea corylifolia and Sanguinaria canadensis
..-
Fonte:s.l; s.n; 2002. 11 p. ilus, tab.
Resumo:Extracts from forty-three plant species were selected on account of reported traditional uses for the treatment of TB and/or leprosy. These were assayed for antimycobacterial activities. A simple in vitro screening assay was employed using two model species of mycobacteria, M. aurum and M. smegmatis. Crude methanolic extracts from three of the plants, C. mukul, P. corylifolia and S. canadensis, were found to have significant antimycobacterial activity against M. aurum only (MIC=62.5 microg/ml). Bioassay guided fractionation led to the isolation of two known benzophenanthridine alkaloids, sanguinarine (1) and chelerythrine (2), from the roots S. canadensis and the known phenolic meroterpene, bakuchiol (3) from the seeds of P. corylifolia. The fractionation of the resin of C. mukul lead to a decrease in antimycobacterial activity and hence further work was not pursued. Compound (2) was the most active against M. aurum and M. smegmatis (IC(50)=7.30 microg/ml [19.02 microM] and 29.0 microg/ml [75.56 microM], respectively). M. aurum was the most susceptible organism to all three compounds. No significant difference in antimycobacterial activity was observed when the two alkaloids were tested for activity in media of differing pH values. The activities of the pure compounds against M. aurum were comparable with those against M. bovis BCG with compound (2) being the most active (M. bovis BCG, IC(50)=14.3 microg/ml [37.3 microM]). These results support the use of these plants in traditional medicine. (AU).
Descritores:ANTITUBERCULOSOS/isol
ANTITUBERCULOSOS/uso terap
AVALIACAO DE MEDICAMENTOS/métodos
HANSENOSTATICOS/isol
HANSENOSTATICOS/uso terap
MYCOBACTERIUM/ef drogas
EXTRATOS VEGETAIS/uso terap
MEDICINA TRADICIONAL
FITOTERAPIA
Psoralea
Limites:HUMANO
SUPPORT, NON-U.S. GOV'T
Meio Eletrônico: - .
Localização:BR191.1; 09050/s


  3 / 6 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:18480
Autor:Abate, Getahun
Título:Drug-resistant tuberculosis in Ethiopia: problem scenarios and recommendation
..-
Fonte:s.l; s.n; 2002. 8 p. tab.
Resumo:Tuberculosis (TB) is a major public health problem in Ethiopia. This review is prepared to indicate possible future challenges related to tuberculosis control and it includes previous reports of drug-resistant surveys in Ethiopia. Drug-resistant TB, both initial and acquired, was reported from different regions of the country. In studies from 1984 to 2001, the initial resistance to isoniazid ranges from 2 per cent to 21 per cent and initial resistance to streptomycin ranges from 2 to 20 per cent. Multidrug-resistance (MDR) TB defined as resistance to at least isoniazid and rifampicin was also reported in about 1.2 per cent of new cases and 12 per cent of re-treatment cases. In all studies which included ethambutol susceptibility test, ethambutol resistance is either nil or very low (below 0.5 per cent). All MDR isolates were susceptible to ethambutol. Treatment and re-treatment regimens recommended by the National TB/Leprosy Control Program could be effective on all cases other than those with MDR-TB. MDR-TB is difficult to cure. Therefore, special emphasis should be given to control the spread of MDR-TB. Lack of control efforts may lead to the increased resistance to both first- and second-line drugs. A well supported and controlled special treatment unit, which uses both first-line and second-line drugs is required for a proper management of these cases and for effective control of the spread of MDR-TB. A uniform susceptibility to ethambutol can be taken as an advantage to develop standard low-cost re-treatment regimen for MDR-TB patients. (AU).
Descritores:ANTITUBERCULOSOS/uso terap
ETIOPIA/epidemiol
MYCOBACTERIUM TUBERCULOSIS/ef drogas
TUBERCULOSE RESISTENTE A MULTIPLAS DROGAS/quimioter
TUBERCULOSE RESISTENTE A MULTIPLAS DROGAS/epidemiol
Limites:HUMANO
Meio Eletrônico: - .
Localização:BR191.1; 09041/s


  4 / 6 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:17939
Autor:Opromolla, Diltor Vladimir Araujo
Título:Results obtained with morphazinamide in the treatment of leprosy
..-
Fonte:s.l; s.n; 1966. 15 p. ilus, tab, graf.
Resumo:The results obtained with morphazinamide in a group of patients with lepromatous leprosy are presented. The drug was administered at the rate of 2gm daily for 6 months Clinically, the drug proved of value in treatment of leprosy. The results of bacilloscopic studies and histologic examinations were favorable, but insufficient to confirm the clinical impression The drug was perfectly tolerated It is recommended that other hospitals and institutions conduct trials with morphazinamide in order to rech final conclusions as to the drug´s antileprotic action, the appropriate dosage and duration of treatment, toleration, and the possibility of using morphazinamide in association with other suitable drugs.(AU).
Descritores:HANSENIASE/quimioter
ANTITUBERCULOSOS/uso terap
PIRAZINAS/uso terap
Limites:HUMANO
Meio Eletrônico: - .
Localização:BR191.1; 00595/s


  5 / 6 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:17779
Autor:Opromolla, Diltor Vladimir Araujo
Título:Results obtained with morphazinamide in the treatment of leprosy
..-
Fonte:s.l; s.n; 1966. 15 p. tab, graf, ilus.
Resumo:The results obtained with morphazinamide in a group of patients with lepromatous leprosy are presented. The drug was administered at the rate of 2 gm daily for 6 months. Clinically, the group proved of value in the treatment of leprosy. The results of bacilloscopic studies and histologic examinations were favorable, but insufficient to confirm the clinical impression. The drug was perfectly tolerated. It is recommended that other hospitals and institutions conduct clinical trials with morphazinamide in order to reach final conclusions as to the drug's antileprotic action, the appropriate dosage and duration of treatment, toleration, and the possibility of using morphazinamide in association with other suitable drugs. (AU).
Descritores:HANSENIASE/quimioter
PIRAZINAS/uso terap
ANTITUBERCULOSOS/uso terap
Limites:HUMANO
Meio Eletrônico: - .
Localização:BR191.1; 00595/s


  6 / 6 HANSEN  
              first record previous record
seleciona
para imprimir
Id:15483
Autor:Skamene, Emil; Schurr, Erwin; Gros, Philippe
Título:Infection genomics: Nramp1 as a major determinant of natural resistance to intracellular infections
..-
Fonte:s.l; s.n; 1998. 13 p. .
Descritores:ALELOS
ANTITUBERCULOSOS
INFECÇOES BACTERIANAS
INFECÇOES BACTERIANAS
INFECÇOES BACTERIANAS
INFECÇOES BACTERIANAS
PROTEINAS DE TRANSPORTE
SURTOS DE DOENÇAS
SUSCETIBILIDADE A DOENÇA
GENOMA BACTERIANO
GENOMA HUMANO
GENOMA DE PROTOZOARIO
LEISHMANIOSE
LEISHMANIOSE
IMUNIDADE NATURAL
LEPROSTATICOS
HANSENIASE
HANSENIASE
HANSENIASE
HANSENIASE
LIGAÇAO (GENÉTICA)
MACROFAGOS
PROTEINAS DA MEMBRANA
CAMUNDONGOS
MYCOBACTERIUM LEPRAE
MYCOBACTERIUM LEPRAE
MYCOBACTERIUM TUBERCULOSIS
MYCOBACTERIUM TUBERCULOSIS
INFECÇOES POR SALMONELLA
INFECÇOES POR SALMONELLA
TUBERCULOSE
TUBERCULOSE
TUBERCULOSE
TUBERCULOSE
Predisposição Genética para Doença
Limites:ESTUDO COMPARATIVO
ANIMAL
Localização:BR191.1; 08338/s



página 1 de 1
   


Refinar a pesquisa
  Base de dados : HANSEN Formulário avançado   
Pesquisar por : Formulário livre   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6.1 powered by WWWISIS

BIREME/PAHO/WHO - Latin American and Caribbean Center on Health Sciences Information